Opinion

Video

Select Ongoing Trials for nccRCC and Impact on the Treatment Landscape

Author(s):

Pedro Barata, MD, MSc,Martin H. Voss, MD

  1. Please review ongoing trials for patients with nccRCC and discuss the potential impact of these studies on the treatment landscape.
  2. Phase 2 KEYNOTE-B61 trial, comparing len + pembro in 1L nccRCC 
  3. Please provide a brief background surrounding KEYNOTE-B61
  4. Please discuss extended follow-up presented at ASCO GU 2024
  5. Phase 2 trial assessing nivo + cabo (
Related Videos
2 KOLs are featured in this series.
5 KOLs are featured in this series.
5 KOLs are featured in this series.
5 KOLs are featured in this series.
2 KOLs are featured in this series.
2 KOLs are featured in this series.
Related Content
Advanced Systemic Mastocytosis: Expert Insight into Epidemiology, Diagnosis, and Treatment
September 15th 2021

Advanced Systemic Mastocytosis: Expert Insight into Epidemiology, Diagnosis, and Treatment